Clinical laboratory test findings in patients with chronic fatigue syndrome.
Bates, D W, Buchwald, D, Lee, J et al. · Archives of internal medicine · 1995
Quick Summary
Researchers compared blood test results from 579 ME/CFS patients with results from 147 healthy people. They found that ME/CFS patients were much more likely to have certain abnormal results, particularly immune-related changes like unusual white blood cells and immune complexes. However, no single test was abnormal enough in all patients to serve as a reliable diagnostic tool on its own.
Why It Matters
This study provided early evidence that ME/CFS involves measurable immune system abnormalities rather than being purely psychological, lending biological credibility to the diagnosis when it was still frequently dismissed. Identifying patterns of immune dysfunction may help researchers understand ME/CFS pathophysiology and eventually develop targeted treatments. The multicenter, geographically diverse design strengthens confidence that findings reflect genuine disease characteristics rather than local variation.
Observed Findings
Circulating immune complexes were 26.5 times more common in ME/CFS patients than controls
Atypical lymphocytosis occurred 11.4 times more frequently in patients with ME/CFS
Antinuclear antibodies were present in 15% of ME/CFS cases but 0% of control subjects
Elevated immunoglobulin G was 8.5 times more common in ME/CFS patients
Abnormal results were comparable between patients recruited in Boston and Seattle, suggesting geographic consistency
Inferred Conclusions
ME/CFS is associated with chronic, low-level activation of the immune system
Multiple readily available laboratory tests can discriminate ME/CFS patients as a group from healthy controls
No single laboratory test possesses sufficient sensitivity to serve as a reliable individual diagnostic marker for ME/CFS
The immunologic abnormalities support a biological basis for ME/CFS rather than a purely functional or psychiatric etiology
Remaining Questions
What is the specificity of these immunologic findings relative to other conditions that cause chronic fatigue (such as autoimmune diseases, malignancies, or depression)?
What This Study Does Not Prove
This study does not establish that any of these laboratory abnormalities *cause* ME/CFS or that they are unique to ME/CFS—the authors explicitly note that specificity relative to other organic and psychiatric conditions producing fatigue remains unestablished. The case-control design cannot determine whether immune abnormalities precede symptom onset or are consequences of chronic illness. No individual test was sensitive or specific enough to serve as a diagnostic biomarker.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →